Iradimed (IRMD) EPS (Basic) Growth (1y) (2014 - 2026)
Iradimed (IRMD) EPS (Basic) Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 13.85% |
| 10 | Iradimed | 1.11 Bn | 1.05 Bn | 15.16 Mn | -10.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.11% |
| Mar 31, 2026 | 23.46% |
| Dec 31, 2025 | 42.54% |
| Sep 30, 2025 | 10.00% |
| Jun 30, 2025 | 17.33% |
| Mar 31, 2025 | 12.85% |
| Dec 31, 2024 | 41.93% |
| Sep 30, 2024 | -0.88% |
| Jun 30, 2024 | 16.62% |
| Mar 31, 2024 | 20.78% |
| Dec 31, 2023 | -16.86% |
| Sep 30, 2023 | 47.41% |
| Jun 30, 2023 | 28.60% |
| Mar 31, 2023 | 36.53% |
| Dec 31, 2022 | -16.27% |
| Sep 30, 2022 | 30.55% |
| Jun 30, 2022 | 116.18% |
| Mar 31, 2022 | 75.85% |
| Dec 31, 2021 | 319.69% |
| Sep 30, 2021 | 138.03% |